logo
Select company
Select metric
Ticker Information

Ticker

GRCE

Company Name

GRACE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GRACE THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GRCE - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -13.11M0%$ 0
3/31/2025$ -14.9M0%$ 0
12/31/2024$ -14.04M0%$ 0
9/30/2024$ -11.81M0%$ 0
6/30/2024$ -9.69M0%$ 0
3/31/2024$ -12.33M0%$ 0
12/31/2023$ -13.57M0%$ 0
9/30/2023$ -15.4M0%$ 0
6/30/2023$ -16.73M0%$ 0
3/31/2023$ -15.91M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for GRACE THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -18.09M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

GRCE - Operating Cash Flow Margin, Last 5 years

-18862.98%

Minimum

Dec 31, 2020

-6914.8%

Maximum

Jun 30, 2021

-10952.52%

Average

-7897.45%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%